|
AU6452098A
(en)
|
1997-03-07 |
1998-09-22 |
Metabasis Therapeutics, Inc. |
Novel purine inhibitors of fructose-1,6-bisphosphatase
|
|
DE69819311T2
(de)
*
|
1997-03-07 |
2004-07-29 |
Metabasis Therapeutics Inc., San Diego |
Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
|
|
WO1999045016A2
(en)
|
1998-03-06 |
1999-09-10 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
ATE246197T1
(de)
|
1998-09-09 |
2003-08-15 |
Metabasis Therapeutics Inc |
Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren
|
|
DE59911249D1
(de)
|
1998-11-03 |
2005-01-13 |
Abbott Gmbh & Co Kg |
Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung
|
|
IL143569A0
(en)
*
|
1998-12-24 |
2002-04-21 |
Metabasis Therapeutics Inc |
A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
|
|
US6756360B1
(en)
|
1998-12-24 |
2004-06-29 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
|
|
US7205404B1
(en)
*
|
1999-03-05 |
2007-04-17 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing prodrugs
|
|
HUP0200260A3
(en)
|
1999-03-05 |
2002-11-28 |
Metabasis Therapeutics Inc San |
Novel phosphorus-containing prodrugs, their preparation and their use
|
|
US6831069B2
(en)
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
|
WO2001018013A1
(en)
*
|
1999-09-08 |
2001-03-15 |
Metabasis Therapeutics, Inc. |
Prodrugs for liver specific drug delivery
|
|
CA2396713A1
(en)
*
|
1999-12-22 |
2001-07-05 |
Metabasis Therapeutics, Inc. |
Novel bisamidate phosphonate prodrugs
|
|
AU2006202624B2
(en)
*
|
1999-12-22 |
2008-08-14 |
Metabasis Therapeutics, Inc. |
Novel bisamidate phosphonate prodrugs
|
|
PT1741446E
(pt)
|
2000-01-21 |
2008-05-09 |
Novartis Pharma Ag |
Combinações incluindo inibidores da dipeptidilpeptidase-iv e agentes anti-diabéticos
|
|
US6919322B2
(en)
*
|
2000-03-08 |
2005-07-19 |
Metabasis Therapeutics, Inc. |
Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors
|
|
US7563774B2
(en)
*
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
|
IL153513A0
(en)
*
|
2000-07-06 |
2003-07-06 |
Metabasis Therapeutics Inc |
A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES
|
|
AU2003235501A1
(en)
*
|
2002-05-13 |
2003-11-11 |
Metabasis Therapeutics, Inc. |
PMEA and PMPA cyclic producing synthesis
|
|
NZ536328A
(en)
|
2002-05-13 |
2007-11-30 |
Metabasis Therapeutics Inc |
Novel phosphonic acid based prodrugs of PMEA and its analogues
|
|
JP5046219B2
(ja)
*
|
2002-10-31 |
2012-10-10 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
１，３−プロパン−１−アリールジオールの新規環状リン酸ジエステルおよびそのプロドラッグへの使用
|
|
CN1882327A
(zh)
|
2003-11-19 |
2006-12-20 |
症变治疗公司 |
含磷的新的拟甲状腺素药
|
|
US7129049B2
(en)
*
|
2003-12-22 |
2006-10-31 |
Regents Of The University Of Minnesota |
Method of detecting equine glycogen storage disease IV
|
|
WO2005123729A1
(en)
*
|
2004-06-08 |
2005-12-29 |
Metabasis Therapeutics, Inc. |
Lewis acid mediated synthesis of cyclic esters
|
|
JP2008510018A
(ja)
*
|
2004-08-18 |
2008-04-03 |
メタバシス・セラピューティクス・インコーポレイテッド |
フルクトース−１，６−ビスホスファターゼの新規チアゾール阻害物質
|
|
US7728026B2
(en)
|
2005-04-11 |
2010-06-01 |
Abbott Laboratories, Inc. |
2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
|
|
TWI375673B
(en)
|
2005-04-11 |
2012-11-01 |
Abbott Lab |
1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
|
|
TW200720255A
(en)
|
2005-07-13 |
2007-06-01 |
Taiho Pharmaceutical Co Ltd |
Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
|
|
EP1752450A1
(en)
|
2005-08-01 |
2007-02-14 |
Merck Sante |
Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
|
|
PL1931350T5
(pl)
|
2005-09-14 |
2021-11-15 |
Takeda Pharmaceutical Company Limited |
Podanie inhibitorów dipeptydylo-peptydazy
|
|
WO2007059230A2
(en)
|
2005-11-15 |
2007-05-24 |
Abbott Laboratories |
Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
|
|
CA2647373C
(en)
|
2006-05-02 |
2014-03-18 |
Abbott Laboratories |
Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
|
|
US8466096B2
(en)
*
|
2007-04-26 |
2013-06-18 |
Afton Chemical Corporation |
1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
|
|
US8067613B2
(en)
|
2007-07-16 |
2011-11-29 |
Abbott Laboratories |
Benzimidazole poly(ADP ribose)polymerase inhibitors
|
|
EP2058308A1
(fr)
|
2007-11-12 |
2009-05-13 |
Merck Sante |
Dérivés de benzimidazoledihydrothiadiazinone comme inhibiteurs de fructose-1,6-biphosphatase et compositions pharmaceutiques les contenant.
|
|
EP2294066B9
(en)
|
2008-04-28 |
2015-03-11 |
Janssen Pharmaceutica, N.V. |
Benzoimidazoles as prolyl hydroxylase inhibitors
|
|
CN102361857B
(zh)
|
2008-09-26 |
2015-09-16 |
默沙东公司 |
可用作抗糖尿病剂的环状苯并咪唑衍生物
|
|
WO2010047982A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
JP5557845B2
(ja)
*
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
|
JO2870B1
(en)
|
2008-11-13 |
2015-03-15 |
ميرك شارب اند دوهم كورب |
Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes
|
|
JP5514831B2
(ja)
|
2008-11-17 |
2014-06-04 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病の治療のための置換二環式アミン
|
|
WO2010083199A1
(en)
|
2009-01-19 |
2010-07-22 |
Abbott Laboratories |
Benzthiazole inhibitors of poly(adp-ribose)polymerase
|
|
US20120046364A1
(en)
|
2009-02-10 |
2012-02-23 |
Metabasis Therapeutics, Inc. |
Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
|
|
EP2805951B1
(en)
|
2009-03-20 |
2018-03-14 |
Metabasis Therapeutics, Inc. |
Inhibitors of diacylglycerol o-acyltransferase 1 (DGAT-1) and uses thereof
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
EP2464228B1
(en)
|
2009-08-13 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
|
|
CA2771352A1
(en)
|
2009-09-02 |
2011-03-10 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
WO2011041293A1
(en)
|
2009-09-30 |
2011-04-07 |
Takeda Pharmaceutical Company Limited |
Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
|
|
PL2531501T3
(pl)
|
2010-02-03 |
2014-05-30 |
Takeda Pharmaceuticals Co |
Inhibitory kinazy 1 regulującej sygnał apoptotyczny
|
|
US8853212B2
(en)
|
2010-02-22 |
2014-10-07 |
Merck Sharp & Dohme Corp |
Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
|
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2011146358A1
(en)
|
2010-05-21 |
2011-11-24 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
|
US8742110B2
(en)
|
2010-08-18 |
2014-06-03 |
Merck Sharp & Dohme Corp. |
Spiroxazolidinone compounds
|
|
JP5719028B2
(ja)
|
2010-10-06 |
2015-05-13 |
グラクソスミスクライン エルエルシー |
Ｐｉ３キナーゼ阻害剤としてのベンズイミダゾール誘導体
|
|
BR112013021236B1
(pt)
|
2011-02-25 |
2021-05-25 |
Merck Sharp & Dohme Corp |
composto derivado de benzimidazol, e, composição
|
|
WO2012138845A1
(en)
|
2011-04-08 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
|
|
US20140088124A1
(en)
|
2011-06-02 |
2014-03-27 |
Robert J. DeVita |
Imidazole derivatives
|
|
US9006228B2
(en)
|
2011-06-16 |
2015-04-14 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment
|
|
US9422266B2
(en)
|
2011-09-30 |
2016-08-23 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
|
|
US9018200B2
(en)
|
2011-10-24 |
2015-04-28 |
Merck Sharp & Dohme Corp. |
Substituted piperidinyl compounds useful as GPR119 agonists
|
|
US9273034B2
(en)
|
2011-10-25 |
2016-03-01 |
Janssen Pharmaceutica Nv |
Meglumine salt formulations of 1-(5,6-dichloro-1H-benzo[D]imidazol-2-yl)-1H-pyrazole-4-carboxylic acid
|
|
WO2013068328A1
(en)
|
2011-11-07 |
2013-05-16 |
Intervet International B.V. |
Bicyclo [2.2.2] octan-1-ylcarboxylic acid compounds as dgat-1 inhibitors
|
|
WO2013068439A1
(en)
|
2011-11-09 |
2013-05-16 |
Intervet International B.V. |
4-amino-5-oxo-7,8-dihydropyrimido[5, 4 -f] [1, 4] oxazepine compounds as dgat1 inhibitors
|
|
AU2012339870B2
(en)
|
2011-11-15 |
2017-06-29 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds useful as GPR119 agonists
|
|
WO2013122920A1
(en)
|
2012-02-17 |
2013-08-22 |
Merck Sharp & Dohme Corp. |
Dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
WO2013155600A1
(en)
|
2012-04-16 |
2013-10-24 |
Kaneq Pharma |
Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors
|
|
EP2874622A4
(en)
|
2012-07-23 |
2015-12-30 |
Merck Sharp & Dohme |
TREATMENT OF DIABETES WITH DIPEPTIDYLPEPTIDASE IV INHIBITORS
|
|
US9527875B2
(en)
|
2012-08-02 |
2016-12-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
RU2015109706A
(ru)
|
2012-08-22 |
2016-10-10 |
Мерк Шарп И Доум Корп. |
Новые производные азабензимидазол гексагидрофуро[3, 2-в]фурана
|
|
WO2014031517A1
(en)
|
2012-08-22 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
Novel azabenzimidazole tetrahydrofuran derivatives
|
|
US9540364B2
(en)
|
2012-08-22 |
2017-01-10 |
Merck Sharp & Dohme Corp. |
Benzimidazole tetrahydrofuran derivatives
|
|
WO2014031465A1
(en)
|
2012-08-22 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
Novel azabenzimidazole tetrahydropyran derivatives
|
|
WO2014031468A1
(en)
|
2012-08-22 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
Novel benzimidazole hexahydrofuro[3,2-b]furan derivatives
|
|
US9527839B2
(en)
|
2012-08-22 |
2016-12-27 |
Merck Sharp & Dohme Corp. |
Benzimidazole tetrahydropyran derivatives
|
|
EP2931734B1
(en)
|
2012-12-17 |
2020-12-02 |
Merck Sharp & Dohme Corp. |
Novel glucokinase activator compounds, compositions containing such compounds, and methods of treatment
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
ES2747973T3
(es)
|
2013-11-15 |
2020-03-12 |
Merck Sharp & Dohme |
Compuestos tricíclicos antidiabéticos
|
|
WO2015089809A1
(en)
|
2013-12-19 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Antidiabetic substituted heteroaryl compounds
|
|
WO2015112465A1
(en)
|
2014-01-24 |
2015-07-30 |
Merck Sharp & Dohme Corp. |
Isoquinoline derivatives as mgat2 inhibitors
|
|
JP2017512183A
(ja)
|
2014-02-13 |
2017-05-18 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
プロドラッグ化合物およびそれらの使用
|
|
WO2015176267A1
(en)
|
2014-05-22 |
2015-11-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
CN106687118A
(zh)
|
2014-07-02 |
2017-05-17 |
配体药物公司 |
前药化合物及其用途
|
|
US10662171B2
(en)
|
2014-08-08 |
2020-05-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
WO2016022446A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[5,6]-fused bicyclic antidiabetic compounds
|
|
US10968193B2
(en)
|
2014-08-08 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
CR20170164A
(es)
|
2014-10-24 |
2017-08-29 |
Merck Sharp & Dohme |
Coagonistas de los receptores de glucagón y de glp-1
|
|
PL3212226T3
(pl)
|
2014-10-31 |
2020-11-02 |
Ngm Biopharmaceuticals, Inc. |
Kompozycje i sposoby stosowania w leczeniu zaburzeń metabolicznych
|
|
TW201625635A
(zh)
|
2014-11-21 |
2016-07-16 |
默沙東藥廠 |
作為可溶性鳥苷酸環化酶活化劑之三唑并吡基衍生物
|
|
EP3078378B1
(en)
|
2015-04-08 |
2020-06-24 |
Vaiomer |
Use of factor xa inhibitors for regulating glycemia
|
|
EP3303342B1
(en)
|
2015-05-27 |
2021-03-17 |
Merck Sharp & Dohme Corp. |
Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activators
|
|
WO2016191335A1
(en)
|
2015-05-28 |
2016-12-01 |
Merck Sharp & Dohme Corp. |
Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activators
|
|
EP3359191A4
(en)
|
2015-10-05 |
2019-05-29 |
Merck Sharp & Dohme Corp. |
ANTIBODY PEPTIDE CONJUGATES WITH AGONISTEACTIVITY ON GLUCAGON RECEPTORS AND GLUCAGON-LIKE PEPTIDE-1
|
|
WO2017095724A1
(en)
|
2015-11-30 |
2017-06-08 |
Merck Sharp & Dohme Corp. |
Aryl sulfonamides as blt1 antagonists
|
|
WO2017107052A1
(en)
|
2015-12-22 |
2017-06-29 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase stimulators
|
|
WO2017197555A1
(en)
|
2016-05-16 |
2017-11-23 |
Merck Sharp & Dohme Corp. |
Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators
|
|
WO2017201683A1
(en)
|
2016-05-25 |
2017-11-30 |
Merck Sharp & Dohme Corp. |
Substituted tetrahydroisoquinoline compounds useful as gpr120 agonists
|
|
WO2018034918A1
(en)
|
2016-08-15 |
2018-02-22 |
Merck Sharp & Dohme Corp. |
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
|
|
EP3496715B1
(en)
|
2016-08-15 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
|
|
US11008313B2
(en)
|
2016-09-20 |
2021-05-18 |
Merck Sharp & Dohme Corp. |
Substituted 1-methyl-1,2,3,4-tetrahydroisoquinoline molecules as PCSK9 allosteric binders
|
|
WO2018093698A1
(en)
|
2016-11-18 |
2018-05-24 |
Merck Sharp & Dohme Corp. |
Indole derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
|
|
AU2017360939B2
(en)
|
2016-11-18 |
2022-03-03 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
|
|
WO2018107415A1
(en)
|
2016-12-15 |
2018-06-21 |
Merck Sharp & Dohme Corp. |
Hydroxy isoxazole compounds useful as gpr120 agonists
|
|
RU2020126177A
(ru)
|
2018-01-09 |
2022-02-10 |
Лиганд Фармасьютикалз, Инк. |
Ацетальные соединения и их терапевтическое применение
|
|
IL279363B2
(en)
|
2018-06-21 |
2025-12-01 |
Merck Sharp & Dohme |
Pcsk9 antagonist compounds
|
|
US12281109B2
(en)
|
2019-04-04 |
2025-04-22 |
Merck Sharp & Dohme Llc |
Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
|
|
EP4021919A1
(en)
|
2019-08-30 |
2022-07-06 |
Merck Sharp & Dohme Corp. |
Pcsk9 antagonist compounds
|
|
EP3842449A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled olefin co-agonists of the glucagon and glp-1 receptors
|
|
EP3842061A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled triazole co-agonists of the glucagon and glp-1 receptors
|
|
EP3842060A1
(en)
|
2019-12-23 |
2021-06-30 |
Merck Sharp & Dohme Corp. |
Stapled lactam co-agonists of the glucagon and glp-1 receptors
|
|
EP4153584A1
(en)
|
2020-05-18 |
2023-03-29 |
Merck Sharp & Dohme LLC |
Novel diacylglyceride o-acyltransferase 2 inhibitors
|
|
EP4225735A1
(en)
|
2020-10-08 |
2023-08-16 |
Merck Sharp & Dohme LLC |
Preparation of oxindole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors
|
|
MA61866B1
(fr)
|
2020-10-08 |
2026-02-27 |
Merck Sharp & Dohme Llc |
Préparation de dérivés de benzimidazolone servant de nouveaux inhibiteurs de diacylglycéride o-acyltransférase 2
|
|
WO2023023245A1
(en)
|
2021-08-19 |
2023-02-23 |
Merck Sharp & Dohme Llc |
Compounds for treating conditions related to pcsk9 activity
|
|
CN119866342A
(zh)
|
2022-06-15 |
2025-04-22 |
默沙东有限责任公司 |
用于捕获白介素-1β的环肽
|
|
AR131250A1
(es)
|
2022-12-02 |
2025-02-26 |
Merck Sharp & Dohme Llc |
Preparación de derivados condensados de azol como nuevos inhibidores de la diacilglicerol o-aciltransferasa 2
|
|
US20250152658A1
(en)
|
2023-11-14 |
2025-05-15 |
Merck Sharp & Dohme Llc |
Cyclic peptide for trapping interleukin-1 beta
|
|
TW202542176A
(zh)
|
2023-12-15 |
2025-11-01 |
美商默沙東有限責任公司 |
用於治療動脈粥樣硬化及發炎病症之環狀肽IL-1β捕捉劑
|
|
WO2026019977A1
(en)
|
2024-07-19 |
2026-01-22 |
Merck Sharp & Dohme Llc |
Pyrrolopyridazine vegfr inhibitors
|